Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
500 participants
OBSERVATIONAL
2018-11-30
2019-02-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Early Use of Caffeine Citrate in Preterm Neonates
NCT04001712
Caffeine as Respiratory Stimulant in Preterm Infants
NCT04144712
Effect of Caffeine on Heart Rate Variability in Newborns
NCT04869176
Immediate Skin-To-Skin Contact and Early Breastfeeding During Caesarean Section
NCT06543160
Hemodynamic Effects of Delayed Umbilical Cord Clamping in Full-term Newborns
NCT04358822
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
but also with a higher risk of chronic diseases such as type 2 diabetes and cardiovascular diseases in adult life
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pregnant ladies who are caffeine using
ladies who uses caffeine during pregnancy
Questionaire
A questionaire will be made to pregnant ladies who take caffeine during pregnancy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionaire
A questionaire will be made to pregnant ladies who take caffeine during pregnancy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pregnant females attending regular post-natal care visits
Exclusion Criteria
* Cardiovascular disease
* Neoplasms
* Current diabetes mellitus, pregnancy induced diabetes
* Renal impairment (serum creatinine 120 mol/liter), and hypertension (blood pressure 140/85 mm Hg).
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kasr El Aini Hospital
OTHER
Aljazeera Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mahmoud Alalfy
Role: STUDY_CHAIR
Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Algazeerah and Kasralainy hospital
Giza, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ahmed Elgazzar, M.D
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
low birth weight
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.